Cargando…

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study

While current live, oral rotavirus vaccines (LORVs) are reducing severe diarrhea everywhere, their effectiveness is lower in high burden settings. Alternative approaches are in advanced stages of clinical development, including injectable next-generation rotavirus vaccine (iNGRV) candidates, which h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debellut, Frédéric, Pecenka, Clint, Hausdorff, William P., Clark, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Rotavirus – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009916/ https://www.ncbi.nlm.nih.gov/pubmed/35240926 http://dx.doi.org/10.1080/21645515.2022.2040329

Ejemplares similares

Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico
por: Gomez, Jorge, et al.
Publicado: (2023)

Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
por: Wang, Xiaoqian, et al.
Publicado: (2023)

Impact of rotavirus vaccine introduction in Abidjan, Côte d’Ivoire
por: Britoh Mlan, Alice, et al.
Publicado: (2023)

Cost-effectiveness analysis of introducing rotavirus vaccine into immunization program in Zhejiang province, China: A decision tree-Markov model study
por: Lv, Huakun, et al.
Publicado: (2023)

Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines
por: Hausdorff, William P., et al.
Publicado: (2022)

Parental preferences for rotavirus vaccination for their children under 5 years old in China: A discrete choice experiment
por: Ma, Wenwen, et al.
Publicado: (2023)

Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
por: Zhou, Yan, et al.
Publicado: (2023)

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
por: Wu, Zhi-Wei, et al.
Publicado: (2023)

Established and new rotavirus vaccines: a comprehensive review for healthcare professionals
por: Vetter, Volker, et al.
Publicado: (2021)

Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges
por: Angel, Juana, et al.
Publicado: (2014)

Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2018)

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
por: Pecenka, Clint, et al.
Publicado: (2018)

Burden of rotavirus gastroenteritis on caregivers: Findings from a systematic literature review
por: Carias, Cristina, et al.
Publicado: (2022)

Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
por: Debellut, Frédéric, et al.
Publicado: (2022)

Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs
por: Wang, Jiahao, et al.
Publicado: (2022)

Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era
por: Kozawa, Kei, et al.
Publicado: (2022)

Clinical characteristics, health care resource utilization and direct medical costs of Rotavirus hospitalizations in Spain (2013–2018)
por: Arístegui, Javier, et al.
Publicado: (2022)

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
por: Pecenka, Clint, et al.
Publicado: (2020)

Cost-effectiveness of rotavirus vaccination in Mozambique
por: Lourenço Guimarães, Esperança, et al.
Publicado: (2022)

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
por: Geard, Nicholas, et al.
Publicado: (2022)

Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
por: Lusvan, Munkh-Erdene, et al.
Publicado: (2019)

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2019)

Rotavirus and the web: analysis of online conversations in Italy during 2020
por: Marchetti, Federico, et al.
Publicado: (2021)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness
por: Owusu, Richmond, et al.
Publicado: (2023)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Economic evaluation of rotavirus vaccination in children of Bhutan
por: Pempa, et al.
Publicado: (2020)

Estimating the global impact of rotavirus vaccines on child mortality
por: Clark, Andrew, et al.
Publicado: (2023)

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh
por: Pecenka, Clint, et al.
Publicado: (2017)

The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers
por: Chen, Jessie, et al.
Publicado: (2022)

Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
por: Baral, Ranju, et al.
Publicado: (2020)

Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2020)

Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study
por: Villanueva-Uy, Maria Esterlita T., et al.
Publicado: (2021)

Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031
por: Nonvignon, Justice, et al.
Publicado: (2018)

Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework
por: Debellut, Frédéric, et al.
Publicado: (2022)

Importance of next-generation diagnostics in control of tuberculosis in LMICs
por: Hasan, Zahra, et al.
Publicado: (2021)

National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study
por: Price, Jessica, et al.
Publicado: (2022)

Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries
por: Mooney, Jessica, et al.
Publicado: (2022)

Análisis exploratorio de datos sobre Gastroenteritis por Rotavirus en niños menores de 5 años en el Hospital General de Veracruz, S.S.A. 1995-2000
por: Martínez Cázares, Maria Teresa
Publicado: (2001)

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study
por: Anderson, John D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nqa98qo87ju9vmj8ag8827nrhf